Background/Objectives: Carotenoids are potentially malabsorbed in patients with chronic pancreatitis (CP). The aims of this study were: (1) to determine the prevalence of low levels of each of the major carotenoids in subjects with CP; (2) to compare carotenoids in CP subjects with or without vascular disease and (3) to test the effect of an increase in dietary lycopene intake in patients with low plasma lycopene concentration. Subjects/Methods: Simultaneous determination of carotenoids was done in 80 patients with CP and 20 healthy subjects, using high-performance liquid chromatography. Of the CP patients who had low lycopene concentration, 22 (o120 mg/l) had to consume daily 40 g tomato paste (approximately 24 mg lycopene). Results: Of these patients, 84.7% had at least one carotenoid deficiency and 27.5% had more than four carotenoid deficiencies. Low plasma concentrations in b-carotene and lycopene were correlated, in CP group, with a low body mass index (BMI), a low low-density lipoprotein (LDL) cholesterol concentration, alcohol consumption and current smoking status, whereas low plasma concentration in b-cryptoxanthine was correlated with a low BMI, a low LDL cholesterol concentration and alcohol consumption. Lycopene concentration was decreased in patients with vascular disease (171 ± 197 vs 99 ± 72 mg/l; P ¼ 0.02). After an intervention period of 8±2 months, lycopene concentration increased from 67.5±30 to 121.8±102 mg/l (P ¼ 0.025). Conclusion: Carotenoid concentrations are dramatically decreased in CP, especially lycopene in CP patients with vascular disease. Despite malabsorption, it is possible to increase lycopene plasma concentration by increasing heated tomato consumption.
Introduction
Patients with exocrine pancreatic insufficiency are at a greater risk of developing vitamin or trace-element deficiencies because of malabsorption (Dutta et al., 1982) . The prevalence of lower plasma concentrations of these vitamins and trace elements in patients with chronic pancreatitis (CP) has been reported (Yadav et al., 1991; Quilliot et al., 2001) . Because of a heightened oxidative modification of low-density lipoprotein (LDL) in CP (Steinberg and Witztum, 1990) , accelerated atherosclerosis (Schoenberg et al., 1995; Sweiry and Mann, 1996) could be one of a number of complications associated with this condition (Quilliot et al., 2005) . Carotenoids, which are lipophilic, are likely to be poorly absorbed in CP patients, but could have a role in reducing these complications. They display several biological activities including antioxidant capacity, blue light filtering, modulation of immune function and regulation of cellular differentiation and apoptosis (Bendich and Olson, 1989; Russell, 2006) . In general populations, the dietary intake of vegetables containing carotenoids has been shown to be associated with a decreased risk of chronic disease, such as cancer and cardiovascular disease. Above all, serum and tissue lycopene levels have been found to be inversely related to the incidence of several types of cancer, including breast cancer and prostate cancer. More recently, individual carotenoids have attracted much attention because of their potential nutritional and clinical relevance; for example, the effectiveness of lutein in increasing macular pigments and in improving visual function; the in vitro animal and human evidence suggesting a unique anabolic effect on bone calcification and prevention of osteoporosis from b-cryptoxanthin; and the beneficial role of lycopene in prostate cancer, bone resorption and oxidative stress (Granado et al., 2003; Rao et al., 2007) .
Our aim was to assess the serum levels of the major carotenoids in subjects with CP and to determine parameters that influence carotenoid concentrations. Second, we compared carotenoid concentration in subjects with or without vascular disease. Last, we tested the effect of an increase in dietary lycopene intake on plasma lycopene concentration.
Subjects and methods

Subjects
The study group consisted of 80 CP patients and 20 healthy controls, matched for social category. All CP patients had alcohol-induced CP and 68 were diabetic. All the patients were recruited in the Department of Nutrition. CP was diagnosed according to published criteria based on clinical history and at least two of the following signs: (1) pancreatic calcification on abdominal X-ray ultrasound scan (pancreatic stones evidenced by intrapancreatic hyper-reflective echoes with acoustic shadows behind) specific endoscopic ultrasound lesions (a quantitative analysis with nine possible criteria (hyperechoic foci, hyperechoic strands, lobularity, ductal dilation, ductal irregularity, hyperechoic duct margins, visible side branches, calcifications and cysts (45 criteria)) or characteristic features on endoscopic retrograde pancreatography (irregular dilatation of pancreatic duct branches of variable intensity with scattered distribution throughout the entire pancreas or (2) irregular dilatation of the main pancreatic duct and branches proximal to complete or incomplete obstruction of the main pancreatic duct (with pancreatic stones or protein plugs). All but 2 of 80 patients had calcific pancreatitis. One patient had several pancreatic pseudocysts, and one had specific lesions on endoscopic retrograde pancreatography. The surgical histories included three choledochojejunostomies and four cystic derivations. Patients who had undergone a pancreatectomy or gastrectomy were excluded. In all, 52 patients had stopped all alcohol intake at the time of the study, and 28 had reduced their consumption but were still drinking 430 g/day. The former alcohol consumption was 111 ± 66 g/day (range 50-450 g/day) for a period of 25.5±11.4 years.
Of the diabetic patients, 41% had no history of pain; diabetes and pancreatic calculus were the initial manifestations of the disease. The average time between detection of CP and diagnosis of diabetes mellitus was 5.8 years. No patient had had an acute episode of pancreatitis in the previous 2 months, and none of the diabetic patients had had an acute episode in the past 5 years. None of the patients or controls was given additional vitamins or trace elements or any special diet. Diabetic patients received dietetic recommendations according to the American Dietetic Association and the French Diabetic Association (Puel et al., 2004; Franz et al., 2008) .
This study was approved by the ethical committee of Nancy.
Analytical methods
Blood was taken into Vacutainer tubes containing 15% EDTA (Becton Dickinson, Meylan, France) by venepuncture. Samples were analyzed by a quality-controlled high-performance liquid chromatography method used for the simultaneous determination of vitamin A (retinol), and the major carotenoids in serum (lutein, zeaxanthin, a-and b-cryptoxanthin, lycopene and a-and b-carotene) using a Waters 600 E controller equipped with a refrigerated Waters 717 Plus autosampler and a Waters Novapack (Waters Ltd system, Saint Quentin en Yvelines, France) C18 column with a C18 precolumn.
The deficiency cutoff ranges were determined based on a healthy population and are mentioned in Table 2 .
A 72-h stool sample was collected from the patients to evaluate the steatorrhea while they were on their usual domestic diet, to evaluate the fat malabsorption with a standard diet. The daily mean fat excretion in stool was 47 g/day at the time of diagnosis and/or coefficient of fat absorption (%) of o80%. Blood samples were taken from patients after overnight fasting and (where relevant) before their morning insulin injection, on the fifth day of the washout period. Blood samples were centrifuged at 2500 g and the plasma immediately stored at À20 1C. HbA1c (hemoglobin A1c) was determined as a percentage of the total hemoglobin by high-performance liquid chromatography (Diamat, Variant I; Bio-Rad Laboratories, Hercules, CA, USA; normal range: 4.5-6%). The fecal fat was analyzed according to the method of Van de Kamer et al. (1949) .
Vascular disease
In addition to a physical examination, each subject underwent the following investigation: evaluation of the major vascular risk factors (blood pressure, smoking status, body mass index (BMI)) and electrocardiography and Doppler pressure measurements (for calculation of ankle-brachial index) according to practice guidelines. Coronary artery disease was also screened following the European recommendations for the diagnosis of coronary artery disease in people with diabetes (De Backer et al., 2004) . Coronary artery disease was confirmed by coronary angiography and lower arterial disease by echo-Doppler or angiography. Diabetic patients additionally underwent an ophthalmological examination and retinal fluorescein angiography to detect microangiopathy.
Dietary assessments
A 7-day dietary recall and a full dietary history using a food frequency questionnaire were used to determine the calorie and macro-and micro-nutrient intakes. Food models and standard utensils were used to demonstrate portion sizes (Replicated Food Limited, Hobson House, London, UK). Dietary intake was analyzed using a computerized nutrient database (GENI; Micro 6, Nancy, France).
Intervention study
We asked 22 volunteer CP patients who had low lycopene concentration to consume additional heated tomatoes or heated tomato products daily. Low levels were defined arbitrarily as o120 mg/l that corresponded to the level of the inferior tertile of the study group. Subjects taking any dietary supplements, including vitamin and mineral supplements, were excluded. As proposed by Gärtner et al. (1997) , we asked them to consume 40 g tomato paste by day (B24 mg lycopene) or its equivalent as tomato ketchup. The main recommendation was 'no day without tomato'. We re-evaluated the lycopene concentration 8 ± 2 months later.
Compliance and dietary intakes. Compliance with the study protocol was assessed by a qualitative question (yes or no). Two patients admitted that they had not increased their consumption of tomato products, and they have not been included in the analyses.
Statistical analysis
Statistical analysis was performed with Staview statistical software (Los Angeles, CA, USA). Results are expressed as means±s.d.; data were tested for normality by skewness and kurtosis tests.
Univariate and multivariate linear regressions were performed to analyze the effects of factors influencing carotenoid deficiencies. In all instances, Po0.05 was considered to be statistically significant. Differences in baseline serum concentrations, and between patients with or without vascular disease, were assessed by Student's t-test, and differences in baseline serum concentrations between the two experimental days were assessed by two-sided paired Student's t-test.
Results
The clinically relevant characteristics are shown in Table 1 . Healthy control subjects had no alcohol consumption and no smoking habits. The mean age of CP patients was 57 ± 9 years and mean BMI was 25.7±4.5 kg/m 2 . Smoking habits were present in 27/80 patients (33%). Alcohol consumption had stopped in 52/80 subjects (65%). The mean duration of pancreatitis was 16.3±7.7 years. Enzyme treatment was prescribed in all the patients but regularly taken in 49 subjects. Steatorrhea needing enzyme treatment when on usual diet was at a level of 12±8 g fat per day. This is no significant difference between subjects with or without treatment.
In all, 68 patients were diabetic, of whom 58 were insulin treated, and 10 had oral treatments. The mean duration of the diabetes was 13.4 ± 8.7 years and the mean HbA1c at study entry was 7.8 ± 1.9%. The mean values for fasting plasma lipid and lipoprotein are reported in Table 1 . The BMI correlated with LDL cholesterol (r ¼ 0.27; Po0.05).
The plasma carotenoid concentrations were lower in CP subjects compared with controls (Po0.01). Prevalence of CP subjects having a concentration below normal is shown in Table 2 . Most (84.7%) had at least one deficiency, and 27.5% had more than four deficiencies. All patients had plasma vitamin A concentrations in the normal range (240-900 mg/l; mean ¼ 645 ± 296 mg/l). Analysis of the different carotenoids (Table 3 ) reveals that they are closely associated, with strong correlations between their individual levels, and especially between a-and b-carotene, b-carotene and lycopene and between zeaxanthin and lutein.
Dietary assessment
The mean total caloric intake of CP patients was 2512 ± 644 (1620-4545) kcal/day. Lipids represented 38.4% of the total calorie intake. b-Carotene intake was estimated at a mean of 7.0±3.7 mg/day (range 1.3-14.3). Only one CP patient had a b-carotene intake below the recommended daily dietary allowance of 42.1 mg. There was no apparent relationship between b-carotene intake and b-carotene plasma concentration. Carotenoids and chronic pancreatitis D Quilliot et al
Parameters influencing plasma carotenoid concentrations
Regression analyses were performed in CP group to analyze the effects of independent variables on carotenoid concentrations. Age, steatorrhea, pancreatitis duration, diabetes and HbA1c levels had no significant effect on the analysis. Lower concentrations of plasma b-carotene and lycopene were associated with lower BMI, lower LDL cholesterol concentration, current alcohol consumption and current smoking, whereas b-cryptoxanthine was associated with lower BMI, lower LDL cholesterol concentration and current alcohol consumption, but not with current smoking (Table 4) . Carotenoid levels did not correlate well with carotenoid intake from food.
Carotenoid concentrations in patients with or without vascular disease
In all 22 patients had macro-vascular disease or microangiopathy. In this group, plasma lycopene concentrations alone were lower (171±197 vs 99±72 mg/l; P ¼ 0.02), and this difference was independent of smoking habits, alcohol consumption and BMI.
Intervention study
The intervention study involved 22 CP patients, of whom 18 had vascular disease (Table 5) . Following dietary recommendations to enhance tomato consumption, we observed an increase in lycopene from 67.5 ± 30 to 121.8 ± 102 mg/l (P ¼ 0.025). We did not observe any relationship between the increase in lycopene concentration and the magnitude of steatorrhea or any other clinical or biochemical parameters.
Discussion
CP is associated with a dramatically low carotenoid status, with 84% of these patients having a deficiency state. The risk of carotenoid deficiency is related to overall nutritional status (probably via malabsorption) and also to smoking status and alcohol consumption. Furthermore, we have shown that CP patients with vascular disease have lower concentrations of lycopene than patients without vascular complications. The intervention study showed that, by providing very simple dietary recommendations, it is possible to improve lycopene status, even in patients with malabsorption. A low consumption of carotenoids is probably a significant contributing factor to carotenoid deficiency. Carotenoid levels were closely related to nutritional status, especially with body composition, and with LDL cholesterol, the two being themselves highly correlated, and linked to the severity of exocrine pancreatic insufficiency (Quilliot et al., 2005) . Adipose tissue constitutes a major storage organ for carotenoids. As a result, patients with low BMI have poor reserves of carotenoids. That could partly explain the positive correlation seen between lycopene, b-carotene, b-cryptoxanthine and the BMI. We did not find any relation with steatorrhea; however, the measurement of steatorrhea in feces is a crude marker of exocrine pancreatic insufficiency. Furthermore, pancreatic enzyme treatments were not stopped for the study.
Carotenoids are transported in the plasma by the lipoproteins, especially LDL that carries B55%, admittedly with carotenoid-specific variations (for example, 58-73% carriage of a-and b-carotene and lycopene, whereas lutein and zeaxanthine are mainly associated with high-density lipoprotein) (Clevidence and Bieri, 1993) . In the Physicians' Health Study, both LDL cholesterol and high-density lipoprotein cholesterol levels paralleled carotenoid concentrations (Farwell et al., 2008) , and consequently the low concentrations of LDL cholesterol could at least partly explain the low concentrations of lutein, b-cryptoxanthine and lycopene observed in our study. The low LDL cholesterol concentration in our patients is explained mainly by the malabsorption of bile acids, although the malabsorption of cholesterol may be an additional contributory factor lowering LDL cholesterol concentrations (Vuoristo et al., 1992) .
In agreement with other studies, we showed that smoking and alcohol intake could influence carotenoid levels in blood (Ito et al., 1991; Forman et al., 1995; Brady et al., 1996) . Smokers have been shown to have lower plasma concentrations of most carotenoids (by 18-44%) than nonsmokers (Princen et al., 1992; Tanabe et al., 1992; Pamuk et al., 1994; ; Albanes et al., 1997) and smoking cessation increases plasma levels of carotenoids (Vogel et al., 1997) . Lycopene and b-carotene are the carotenoids most sensitive to the gas phase of cigarette smoke (Handelman et al., 1996) . However, the relationship between circulating concentrations of lycopene and smoking status is still uncertain. One study (Pamuk et al., 1994) found that smokers (n ¼ 91) had 26% lower serum lycopene concentrations than nonsmokers after adjustment for potential confounders, but there are five other studies in which no effect of smoking on plasma lycopene was found.
The European Prospective Investigation into Cancer and Nutrition (EPIC) study of 43000 European subjects has shown that the most important predictors of plasma carotenoid levels are the BMI (partial R 2 ¼ 5.2%), gender (partial R 2 ¼ 2.7%) and smoking status (partial R 2 ¼ 2.8%), except for lycopene concentrations that appear unrelated to smoking. The EPIC study also addressed the effects of alcohol as it has been believed to increase serum carotenoid levels (Ahmed et al., 1994; Forman et al., 1995) . However, in the EPIC study, alcohol contributed little to the variability in carotenoid levels. On the contrary, in the Physicians' Health Study, weekly alcohol ingestion correlated with a decrease in the risk of carotenoid deficiency (Farwell et al., 2008) . A decrease in carotenoid intake in alcoholic patients could be an explanation, but we have not found any consistent differences in fruit or vegetable consumption in our drinkers compared with the general population. The deficit in carotenoids could contribute to the increased risk of pancreatic cancer observed in CP patients. A study of serum collected from 25 802 volunteers has already shown that low levels of serum lycopene are strongly associated with pancreatic cancer, and less strongly so with cancer of the bladder and rectum (Comstock et al., 1991) . In another study, serum levels of lycopene and selenium were lower in patients who had pancreatic cancer than in matched controls (Burney et al., 1989) . Rats given a diet high in b-carotene, vitamin C or selenium, but not vitamin E, developed fewer induced pancreatic tumors than littermate controls (Woutersen et al., 1999) .
Many epidemiologic studies have detected a protective association between carotenoids and the risk of heart disease and/or atherosclerosis (review in Voutilainen et al., 2006) . This effect could be primarily an antioxidant effect. There are several arguments in favor of this oxidative theory of atherosclerosis, and in a previous paper we showed that patients with CP and vascular complications have higher level of anti-malonedialdéhyde.
The intervention study showed that it is possible to increase plasma lycopene concentrations, despite pancreatic malabsorption syndrome, simply by increasing heated tomato consumption. We did not observe improvement in clinical symptoms because of the short length of follow-up. Furthermore, these patients were painless, and hence the effect of lycopene supplementation on pain attack cannot be evaluated in this population. We did not observe any relation between the increment in lycopene concentration and steatorrhea or other parameters. It is probable that the quantity of ingested lycopene is the main determining factor, but unfortunately we could not accurately quantify the lycopene consumption, which was evidently very variable. In the literature, the results of intervention studies vary according to the population and the tomato form. Plasma lycopene concentrations increased only slightly in a group receiving 180 g tomato juice (containing 12 mg lycopene) daily for 6 weeks (Micozzi et al., 1992) . This finding is supported by other studies showing negligible or only slight increases in plasma lycopene concentrations after consumption of various amounts of unheated tomato juice (Brown et al., 1989; Stahl and Sies, 1992) . In one study, however, when heated tomato juice mixed with oil was consumed, serum concentrations of lycopene increased, with a peak 24-48 h after ingestion (Stahl and Sies, 1992) . Similarly, Gärtner et al. (1997) found that concentrations of lycopene in the chylomicrons of five human subjects increased roughly 3 times as much when they consumed tomato paste as when they consumed raw tomatoes. Thus, the availability and absorption of lycopene seem to depend on the processing and treatment of the food that contains the carotenoid and on the fat content of the meal in which lycopene is consumed.
Although the zeaxanthine and cryptoxanthine did not change significantly, there was a notable numerical reduction in their levels. The potential biological significance of this deserves attention in future studies.
Finally, carotenoids can also be implicated in the pathogenesis of several complications of CP. Deficit in carotenoids could contribute to the accelerated osteoporosis of CP patients. The higher than predicted incidences of osteoporosis and of pathological fractures are well known in these patients (Haaber et al., 2000; Dujsikova et al., 2008) despite a recommended higher vitamin D intake. Lycopene and b-cryptoxanthin may have important preventive effects on bone loss and osteoporosis (Rao et al., 2007) .
This study showed that the prevalence of carotenoid deficiencies is very high in CP. The lycopene concentrations are decreased especially in patients with concurrent vascular disease. Despite pancreatic malabsorption, it is possible to increase lycopene plasma concentrations with 40 g of tomato paste taken each day.
